RenaissThera is a pharmaceutical company dedicated to developing affordable, novel small-molecule targeted therapies leveraging AI platforms. Our goal is to innovate for underserved populations and bridge the gaps in novel therapy access worldwide. We focus on high-unmet-need areas of prevalent diseases in cardio-metabolic therapy including diabetes type 2 and obesity.
Leveraging our Innovation Platform powered by GenAI tools, we identify small-molecule therapies for proven pathways, ensuring cutting-edge solutions for patients. With a leadership team and scientific advisory board boasting extensive experience in global pharmaceutical product development, RenaissThera is committed to bringing innovative treatments to those in need around the world.
Company Details
- Employees
- 2
- Founded
- -
- Address
- 7th Block Jayanagar, Bangalore,karnataka,india
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.renaissthera.com
- Keywords
- Small Molecule Therapies, GenAI to Accelerate R&D, Innovate for Emerging Markets, Cardio-metabolic, Diabetes type 2, Obesity.
- HQ
- Bangalore, Karnataka
Renaissthera Questions
Renaissthera's website is http://www.renaissthera.com
Renaissthera's LinkedIn profile is https://in.linkedin.com/company/renaissthera
Renaissthera has
2 employees.
View email and phone details for 2
employees at Renaissthera.
Renaissthera's industry is
Biotechnology Research
Renaissthera's top competitors are
Popvax,
Fable Therapeutics,
Invea Therapeutics,
Bioxcel, Llc,
Vedtechbio,
Legitquest,
Bizom,
Alphameld Corporation,
Iksa.ai,
Vergecloud.
Renaissthera's categories are Biotechnology Research
Renaissthera's founding year is 2023
